STOCK TITAN
  1. Home
  2. Financials
  3. ARMP
  4. EPS (Diluted)

Armata Pharmctcl (ARMP) EPS by Year

ARMP

Armata Pharmctcl lost $4.80 per diluted share in fiscal year 2025. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Armata Pharmctcl has filed alongside them.

FY2025 annual
EPS (Diluted) -$4.80
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ARMP EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25DEF 14AFY24DEF 14AFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-K
EPS (Diluted)-$4.80-$0.89-$1.91-76.9%-$1.08-12.5%-$0.96+28.9%-$1.35-$2.55-$3.59-$2.18-$24.67-$1.99-$2.33-264.1%-$0.64

ARMP EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
EPS (Diluted)-$0.27+40.0%-$3.16-$3.43-1082.8%-$0.74-393.3%-$0.45-80.0%-$0.20+71.0%-$0.29+47.3%-$0.15+82.6%-$0.25-47.1%-$0.69-72.5%-$0.55-89.7%-$0.86-258.3%

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Armata Pharmctcl financials

Frequently Asked Questions

What was Armata Pharmctcl's diluted earnings per share in fiscal year 2025?

Armata Pharmctcl lost $4.80 per diluted share in fiscal year 2025.

How has Armata Pharmctcl's diluted earnings per share changed over the years?

Across the 13 fiscal years this page covers, Armata Pharmctcl (ARMP) diluted earnings per share went from -$0.64 in fiscal year 2013 to -$4.80 in fiscal year 2025.

What was Armata Pharmctcl's diluted earnings per share in the most recent quarter?

Armata Pharmctcl (ARMP) reported -$0.27 in diluted earnings per share in Q2 2026. This represents an increase of 40.0% from the same quarter a year earlier.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Armata Pharmctcl (ARMP) reported on that line in every period on record.